Bio-Rad Laboratories [BIO] vs Masimo [MASI] Detailed Stock Comparison

Bio-Rad Laboratories

NYSE
Loading...

Masimo

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Bio-Rad Laboratories wins in 13 metrics, Masimo wins in 6 metrics, with 0 ties. Bio-Rad Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBio-Rad LaboratoriesMasimoBetter
P/E Ratio (TTM)27.55129.16Bio-Rad Laboratories
Price-to-Book Ratio1.167.67Bio-Rad Laboratories
Debt-to-Equity Ratio19.7361.58Bio-Rad Laboratories
PEG Ratio-0.240.60Bio-Rad Laboratories
EV/EBITDA20.2355.23Bio-Rad Laboratories
Profit Margin (TTM)12.50%-21.32%Bio-Rad Laboratories
Operating Margin (TTM)12.19%17.12%Masimo
EBITDA Margin (TTM)12.19%17.12%Masimo
Return on Equity4.59%-22.37%Bio-Rad Laboratories
Return on Assets (TTM)1.59%1.84%Masimo
Free Cash Flow (TTM)$266.20M$145.30MBio-Rad Laboratories
1-Year Return-11.12%6.09%Masimo
Price-to-Sales Ratio (TTM)3.223.72Bio-Rad Laboratories
Enterprise Value$8.30B$8.49BMasimo
EV/Revenue Ratio3.253.94Bio-Rad Laboratories
Gross Profit Margin (TTM)52.99%62.90%Masimo
Revenue per Share (TTM)$92$40Bio-Rad Laboratories
Earnings per Share (Diluted)$11.09$-5.10Bio-Rad Laboratories
Beta (Stock Volatility)0.971.28Bio-Rad Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bio-Rad Laboratories vs Masimo Stock Performance Analysis

Loading Price Chart...

Bio-Rad Laboratories
Masimo
Bio-Rad Laboratories Stock Overview | Masimo Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bio-Rad Laboratories1.20%12.58%6.05%21.44%30.13%-6.34%
Masimo0.57%4.17%7.69%-12.10%-3.33%-12.62%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bio-Rad Laboratories-11.12%-28.78%-46.04%119.48%234.01%462.39%
Masimo6.09%9.68%-39.24%272.13%417.17%635.71%

News Based Sentiment: Bio-Rad Laboratories vs Masimo

Bio-Rad Laboratories

News based Sentiment: MIXED

October brought a blend of positive and negative developments for Bio-Rad Laboratories. While the stock experienced a short-term decline and a downgrade, strong institutional ownership and a positive analyst outlook suggest underlying confidence. The upcoming earnings report on October 29th will be a key catalyst for determining the company's future direction.

View Bio-Rad Laboratories News Sentiment Analysis

Masimo

News based Sentiment: MIXED

Masimo experienced a significant restructuring with the sale of Sound United, leading to recasted financials. While analyst ratings are mixed, with upgrades and cautious outlooks, positive earnings estimates and insider buying suggest underlying confidence. This combination of events makes October a noteworthy month for investors.

View Masimo News Sentiment Analysis

Performance & Financial Health Analysis: Bio-Rad Laboratories vs Masimo

MetricBIOMASI
Market Information
Market Cap i$8.38B$8.00B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i214,510676,210
90 Day Avg. Volume i238,283651,863
Last Close$309.17$148.13
52 Week Range$211.43 - $387.99$133.17 - $194.88
% from 52W High-20.31%-23.99%
All-Time High$832.70 (Aug 30, 2021)$305.21 (Nov 15, 2021)
% from All-Time High-62.87%-51.47%
Growth Metrics
Quarterly Revenue Growth0.02%0.08%
Quarterly Earnings Growth0.02%2.21%
Financial Health
Profit Margin (TTM) i0.13%-0.21%
Operating Margin (TTM) i0.12%0.17%
Return on Equity (TTM) i0.05%-0.22%
Debt to Equity (MRQ) i19.7361.58
Cash & Liquidity
Book Value per Share (MRQ)$263.42$19.20
Cash per Share (MRQ)$50.76$2.75
Operating Cash Flow (TTM) i$534.20M$176.60M
Levered Free Cash Flow (TTM) i$223.40M$92.86M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Bio-Rad Laboratories vs Masimo

MetricBIOMASI
Price Ratios
P/E Ratio (TTM) i27.55129.16
Forward P/E i26.2231.74
PEG Ratio i-0.240.60
Price to Sales (TTM) i3.223.72
Price to Book (MRQ) i1.167.67
Market Capitalization
Market Capitalization i$8.38B$8.00B
Enterprise Value i$8.30B$8.49B
Enterprise Value Metrics
Enterprise to Revenue i3.253.94
Enterprise to EBITDA i20.2355.23
Risk & Other Metrics
Beta i0.971.28
Book Value per Share (MRQ) i$263.42$19.20

Financial Statements Comparison: Bio-Rad Laboratories vs Masimo

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BIOMASI
Revenue/Sales i$585.40M$372.00M
Cost of Goods Sold i$279.40M$138.00M
Gross Profit i$306.00M$234.00M
Research & Development i$73.50M$33.90M
Operating Income (EBIT) i$23.70M$80.70M
EBITDA i$98.50M$90.70M
Pre-Tax Income i$83.40M$68.40M
Income Tax i$19.40M$21.20M
Net Income (Profit) i$64.00M$-170.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BIOMASI
Cash & Equivalents i$521.40M$130.80M
Total Current Assets i$3.04B$1.18B
Total Current Liabilities i$506.60M$546.50M
Long-Term Debt i$1.33B$657.70M
Total Shareholders Equity i$6.68B$946.40M
Retained Earnings i$7.48B$1.32B
Property, Plant & Equipment i$681.70M$183.60M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BIOMASI
Operating Cash Flow i$156.00M$62.60M
Capital Expenditures i$-34.40M$17.00M
Free Cash Flow i$95.50M$27.00M
Debt Repayment i$-100,000$-78.80M
Common Stock Repurchase i$-101.90MN/A

Short Interest & Institutional Ownership Analysis

MetricBIOMASI
Shares Short i1.11M3.72M
Short Ratio i4.846.13
Short % of Float i0.06%0.10%
Average Daily Volume (10 Day) i214,510676,210
Average Daily Volume (90 Day) i238,283651,863
Shares Outstanding i28.01M53.60M
Float Shares i21.67M46.46M
% Held by Insiders i0.16%0.06%
% Held by Institutions i0.90%1.10%

Dividend Analysis & Yield Comparison: Bio-Rad Laboratories vs Masimo

MetricBIOMASI
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A